• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合酶链反应检测对英国侵袭性脑膜炎奈瑟菌病确诊的附加值。

Added value of PCR-testing for confirmation of invasive meningococcal disease in England.

机构信息

European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden; Immunisation, Hepatitis & Blood Safety Department, Public Health England, London, United Kingdom.

出版信息

J Infect. 2013 Nov;67(5):385-90. doi: 10.1016/j.jinf.2013.06.007. Epub 2013 Jun 22.

DOI:10.1016/j.jinf.2013.06.007
PMID:23796865
Abstract

OBJECTIVES

In England, national guidance recommends that all patients with suspected invasive meningococcal disease (IMD) should be investigated by blood culture and polymerase chain reaction (PCR) testing. The Meningococcal Reference Unit (MRU) provides a national service for meningococcal species confirmation and PCR-testing of clinical samples. We performed a population-level assessment of the added value of PCR-testing for IMD to augment traditional culture confirmation.

METHODS

We analysed all PCR-samples and invasive meningococcal isolates received by MRU in 2009 and 2010. We assumed that all patients with PCR-samples submitted to MRU also had blood cultures performed and that positive blood cultures were referred to MRU. We confirmed this assertion by case ascertainment.

RESULTS

In total, 25,379 specimens from 22,039 patients were submitted for PCR-testing and 1492 (6.8%) tested PCR-positive. MRU received 825 invasive meningococcal isolates; 393 confirmed by PCR and culture, 405 without a PCR-specimen submitted and 27 with a PCR-negative result. Thus, of 1924 reported IMD cases, 1099 (57.1%) were confirmed by PCR only, 432 (22.5%) by culture only and 393 (20.4%) by both tests.

CONCLUSION

More than half of all confirmed IMD cases were confirmed by PCR only, indicating this service ensures high case ascertainment for national surveillance.

摘要

目的

在英国,国家指南建议所有疑似侵袭性脑膜炎球菌病(IMD)的患者均应通过血液培养和聚合酶链反应(PCR)检测进行检查。脑膜炎球菌参考单位(MRU)为脑膜炎球菌种属确认和临床样本的 PCR 检测提供了全国性服务。我们对 PCR 检测对 IMD 的附加价值进行了人群水平评估,以补充传统的培养确认。

方法

我们分析了 2009 年和 2010 年 MRU 收到的所有 PCR 样本和侵袭性脑膜炎球菌分离株。我们假设所有提交给 MRU 的 PCR 样本的患者都进行了血液培养,并且阳性血液培养物都被送到了 MRU。我们通过病例确定来证实这一说法。

结果

总共 22039 名患者的 25379 份标本进行了 PCR 检测,其中 1492 份(6.8%)检测为 PCR 阳性。MRU 收到了 825 株侵袭性脑膜炎球菌分离株;其中 393 株通过 PCR 和培养得到确认,405 株未提交 PCR 样本,27 株 PCR 结果为阴性。因此,在报告的 1924 例 IMD 病例中,1099 例(57.1%)仅通过 PCR 确认,432 例(22.5%)仅通过培养确认,393 例(20.4%)通过两种检测方法确认。

结论

超过一半的确诊 IMD 病例仅通过 PCR 确认,这表明该服务可确保全国监测中的高病例检出率。

相似文献

1
Added value of PCR-testing for confirmation of invasive meningococcal disease in England.聚合酶链反应检测对英国侵袭性脑膜炎奈瑟菌病确诊的附加值。
J Infect. 2013 Nov;67(5):385-90. doi: 10.1016/j.jinf.2013.06.007. Epub 2013 Jun 22.
2
Polymerase chain reaction for diagnosis and serogrouping of meningococcal disease in children.聚合酶链反应在儿童脑膜炎球菌病诊断及血清群分型中的应用
Diagn Microbiol Infect Dis. 2009 Feb;63(2):148-54. doi: 10.1016/j.diagmicrobio.2008.10.008. Epub 2008 Nov 21.
3
Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease.侵袭性脑膜炎球菌病患者基于聚合酶链反应诊断的动态变化
Clin Microbiol Infect. 2006 Feb;12(2):137-41. doi: 10.1111/j.1469-0691.2005.01327.x.
4
Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: Linkage analysis of multiple national databases.英格兰 4619 例实验室确诊侵袭性脑膜炎球菌病住院病例的临床诊断和结局:多个国家数据库的关联分析。
J Infect. 2016 Nov;73(5):427-436. doi: 10.1016/j.jinf.2016.07.016. Epub 2016 Jul 28.
5
Real-time polymerase chain reaction detection of Neisseria meningitidis in formalin-fixed tissues from sudden deaths.福尔马林固定的猝死组织中脑膜炎奈瑟菌的实时聚合酶链反应检测
Diagn Microbiol Infect Dis. 2008 Apr;60(4):339-46. doi: 10.1016/j.diagmicrobio.2007.10.014. Epub 2008 Feb 20.
6
Invasive meningococcal disease in England: assessing disease burden through linkage of multiple national data sources.英格兰的侵袭性脑膜炎球菌病:通过多个国家数据源的关联评估疾病负担。
BMC Infect Dis. 2015 Dec 1;15:551. doi: 10.1186/s12879-015-1247-7.
7
Australian Meningococcal Surveillance Programme annual report, 2013.《2013年澳大利亚脑膜炎球菌监测计划年度报告》
Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E301-8.
8
Clinical features, laboratory findings and management of meningococcal meningitis in England and Wales: report of a 1997 survey. Meningococcal meningitis: 1997 survey report.英格兰和威尔士脑膜炎球菌性脑膜炎的临床特征、实验室检查结果及治疗:1997年调查报告。脑膜炎球菌性脑膜炎:1997年调查报告。
J Infect. 2000 Jan;40(1):74-9. doi: 10.1053/jinf.1999.0595.
9
The impact of meningococcal polymerase chain reaction testing on laboratory confirmation of invasive meningococcal disease.脑膜炎奈瑟菌聚合酶链反应检测对侵袭性脑膜炎奈瑟菌病实验室确诊的影响。
Pediatr Infect Dis J. 2012 Mar;31(3):316-8. doi: 10.1097/INF.0b013e318241f824.
10
Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.英格兰和威尔士与侵袭性疾病相关的地方性脑膜炎奈瑟菌 W 群 11 型序列型 11 复合群的增加。
Clin Infect Dis. 2015 Feb 15;60(4):578-85. doi: 10.1093/cid/ciu881. Epub 2014 Nov 10.

引用本文的文献

1
PCR-positive meningococcal CSF infection without pleocytosis but high IL-6 and IL-8.PCR 阳性但细胞数不增多的脑膜炎奈瑟菌性脑脊液感染,伴有高 IL-6 和 IL-8。
Infection. 2024 Oct;52(5):1681-1684. doi: 10.1007/s15010-024-02275-0. Epub 2024 Apr 27.
2
Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004-2020.2004-2020 年,新西兰奥克兰地区小儿侵袭性脑膜炎奈瑟菌病。
Emerg Infect Dis. 2023 Apr;29(4):686-695. doi: 10.3201/eid2904.221397.
3
Molecular characterization of invasive isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage.
2009-2019 年在立陶宛采集的侵袭性分离株的分子特征及 B 群脑膜炎球菌疫苗 4CMenB 和 MenB-Fhbp 覆盖率的评估。
Front Cell Infect Microbiol. 2023 Feb 15;13:1136211. doi: 10.3389/fcimb.2023.1136211. eCollection 2023.
4
The management of acute meningitis: an update.急性脑膜炎的治疗:最新进展。
Clin Med (Lond). 2022 Sep;22(5):396-400. doi: 10.7861/clinmed.2022-cme-meningitis.
5
Evaluation of Dried Blood and Cerebrospinal Fluid Filter Paper Spots for Storing and Transporting Clinical Material for the Molecular Diagnosis of Invasive Meningococcal Disease.评价用于储存和运输侵袭性脑膜炎奈瑟菌病分子诊断临床标本的干血滤纸片和脑脊液滤纸片。
Int J Mol Sci. 2022 Oct 6;23(19):11879. doi: 10.3390/ijms231911879.
6
Clinical management of community-acquired meningitis in adults in the UK and Ireland in 2017: a retrospective cohort study on behalf of the National Infection Trainees Collaborative for Audit and Research (NITCAR).2017 年英国和爱尔兰成人社区获得性脑膜炎的临床管理:代表国家感染培训生协作进行审计和研究 (NITCAR) 的回顾性队列研究。
BMJ Open. 2022 Jul 13;12(7):e062698. doi: 10.1136/bmjopen-2022-062698.
7
[ (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy].[意大利引入四价结合疫苗进行抗脑膜炎球菌疫苗接种的(卫生技术评估)]
J Prev Med Hyg. 2021 May 13;62(1 Suppl 1):E1-E128. doi: 10.15167/2421-4248/jpmh2021.62.1s1. eCollection 2021 Mar.
8
Toward Establishing Integrated, Comprehensive, and Sustainable Meningitis Surveillance in Africa to Better Inform Vaccination Strategies.建立综合、全面和可持续的非洲脑膜炎监测系统,以更好地为疫苗接种策略提供信息。
J Infect Dis. 2021 Sep 1;224(12 Suppl 2):S299-S306. doi: 10.1093/infdis/jiab268.
9
Deconvolution of intergenic polymorphisms determining high expression of Factor H binding protein in meningococcus and their association with invasive disease.解析决定脑膜炎奈瑟菌高表达因子 H 结合蛋白的基因间多态性及其与侵袭性疾病的关联。
PLoS Pathog. 2021 Mar 26;17(3):e1009461. doi: 10.1371/journal.ppat.1009461. eCollection 2021 Mar.
10
Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy.意大利侵袭性脑膜炎球菌病:从全国数据分析到基于证据的疫苗接种策略。
J Prev Med Hyg. 2020 Jul 4;61(2):E152-E161. doi: 10.15167/2421-4248/jpmh2020.61.2.1589. eCollection 2020 Jun.